Live Feed

Delayed 3m

Analyst · Buys · SEC · FDA

Signed out · 3-min delay · Sign up for real-time

FDA04:55:22·1d·Health Care·
$LCI
FDA Approval for HYDROCODONE BITARTRATE AND ACETAMINOPHEN issued to LANNETT CO INC
Submission status for LANNETT CO INC's drug HYDROCODONE BITARTRATE AND ACETAMINOPHEN (SUPPL-14) with active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE has changed to 'Approval' on 06/18/2026. Application Category: ANDA, Application Number: 207172, Application Classification: REMS
FDA04:55:26·1d·Health Care·
$LCI
FDA Approval for OXYCODONE AND ACETAMINOPHEN issued to LANNETT CO INC
Submission status for LANNETT CO INC's drug OXYCODONE AND ACETAMINOPHEN (SUPPL-18) with active ingredient ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE has changed to 'Approval' on 06/18/2026. Application Category: ANDA, Application Number: 207333, Application Classification: REMS
FDA04:55:20·1d·Health Care·
$LCI
FDA Approval for HYDROCODONE BITARTRATE AND ACETAMINOPHEN issued to LANNETT CO INC
Submission status for LANNETT CO INC's drug HYDROCODONE BITARTRATE AND ACETAMINOPHEN (SUPPL-14) with active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE has changed to 'Approval' on 06/18/2026. Application Category: ANDA, Application Number: 207171, Application Classification: REMS
FDA04:54:17·1d·Health Care·
$LCI
FDA Approval for OXYCODONE HYDROCHLORIDE issued to LANNETT CO INC
Submission status for LANNETT CO INC's drug OXYCODONE HYDROCHLORIDE (SUPPL-16) with active ingredient OXYCODONE HYDROCHLORIDE has changed to 'Approval' on 06/18/2026. Application Category: ANDA, Application Number: 203823, Application Classification: REMS
FDA04:54:10·1d·Health Care·
$LCI
FDA Approval for CODEINE SULFATE issued to LANNETT CO INC
Submission status for LANNETT CO INC's drug CODEINE SULFATE (SUPPL-21) with active ingredient CODEINE SULFATE has changed to 'Approval' on 06/18/2026. Application Category: ANDA, Application Number: 203046, Application Classification: REMS
INSIDER20:25:18·1d·Finance·
$WHF
Director Bolduc John bought $99,816 worth of shares (15,380 units at $6.49) (SEC Form 4)
4 - WhiteHorse Finance, Inc. (0001552198) (Issuer)
SEC20:05:11·1d·Technology·
$BMBL
Amendment: SEC Form SCHEDULE 13D/A filed by Bumble Inc.
SCHEDULE 13D/A - Bumble Inc. (0001830043) (Subject)
SEC20:02:49·1d·Consumer Discretionary·
$LVS
Amendment: SEC Form SCHEDULE 13D/A filed by Las Vegas Sands Corp.
SCHEDULE 13D/A - LAS VEGAS SANDS CORP (0001300514) (Subject)
INSIDER19:01:45·1d·Technology·
$CUEN
Insider, CAIO Oas Energy Llc bought $4,403 worth of shares (16,000 units at $0.28), increasing direct ownership by 21% to 90,421 units (SEC Form 4)
4 - Cuentas Inc. (0001424657) (Issuer)
INSIDER18:55:36·1d·Industrials·
$VMAR
Large owner Hrt Financial Lp bought $68,967 worth of Class A Shares (234,583 units at $0.29) (SEC Form 4)
4 - Vision Marine Technologies Inc. (0001813783) (Issuer)
INSIDER18:23:46·1d·Health Care·
$XRAY
Amendment: Director Mazelsky Jonathan Jay bought $101,400 worth of shares (10,000 units at $10.14), increasing direct ownership by 19% to 61,669 units (SEC Form 4)
4/A - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
SEC18:21:41·1d·Technology·
$SMCI
SEC Form SCHEDULE 13G filed by Super Micro Computer Inc.
SCHEDULE 13G - Super Micro Computer, Inc. (0001375365) (Subject)
SEC17:57:11·1d·Health Care·
$QURE
SEC Form 144 filed by uniQure N.V.
144 - uniQure N.V. (0001590560) (Subject)
SEC17:55:08·1d·Technology·
$DSP
Amendment: SEC Form SCHEDULE 13D/A filed by Viant Technology Inc.
SCHEDULE 13D/A - Viant Technology Inc. (0001828791) (Subject)
INSIDER17:53:03·1d·Consumer Discretionary·
$YYGH
Large owner Hrt Financial Lp bought $338,223 worth of Class A Shares (2,493,128 units at $0.14), increasing direct ownership by 878% to 2,776,970 units (SEC Form 4)
4 - YY Group Holding Ltd. (0001985337) (Issuer)
SEC17:51:22·1d·Health Care·
$TOVX
SEC Form PRE 14A filed by Theriva Biologics Inc.
PRE 14A - Theriva Biologics, Inc. (0000894158) (Filer)
SEC17:47:35·1d·Health Care·
$WGRX
SEC Form PRE 14A filed by Wellgistics Health Inc.
PRE 14A - Wellgistics Health, Inc. (0002030763) (Filer)
SEC17:44:28·1d·Consumer Discretionary·
$HEPS
SEC Form SCHEDULE 13G filed by D-Market Electronic Services & Trading
SCHEDULE 13G - D-MARKET Electronic Services & Trading (0001850235) (Subject)
SEC17:35:50·1d·Health Care·
$KYMR
SEC Form 144 filed by Kymera Therapeutics Inc.
144 - Kymera Therapeutics, Inc. (0001815442) (Subject)
SEC17:35:41·1d·Health Care·
$KYMR
SEC Form 144 filed by Kymera Therapeutics Inc.
144 - Kymera Therapeutics, Inc. (0001815442) (Subject)